[{"Assets_0_Q1_USD":"1255400000.0","CIK":"899923","CommonStockSharesIssued_0_Q1_shares":"80300000.0","CommonStockSharesOutstanding_0_Q1_shares":"80300000.0","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"-0.26","EarningsPerShareDiluted_1_Q1_USD":"-0.26","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"1850258412.0","MinorityInterest_0_Q1_USD":"0.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"-46500000.0","NetIncomeLoss_1_Q1_USD":"-20500000.0","OfficialName":"Myriad Genetics Inc. Common Stock","ProfitLoss_1_Q1_USD":"-20500000.0","RevenuesConverted_1_Q1_USD":"164900000.0","SP500":null,"Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":"950100000.0","StockholdersEquity_0_Q1_USD":"950100000.0","Ticker":"MYGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"80100000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"80100000.0","filed":"20220506","footnote":null,"form":"10-Q","fp":"Q1","fy":"2022.0","name":"MYRIAD GENETICS INC","period":"20220331","qtrs":"0","uom":"USD"}]